Computer-aided approaches reveal trihydroxychroman and pyrazolone derivatives as potential inhibitors of SARS-CoV-2 virus main protease
COVID-19 was declared a pandemic by the World Health Organization (WHO) in March 2020. The disease is caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). The aim of this study is to target the SARS-CoV-2 virus main protease (Mpro) via structure-based virtual screening. Consequentl...
Main Authors: | Atatreh Noor, Hasan Shaima, Ali Bassam R., Ghattas Mohammad A. |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2021-09-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2021-0040 |
Similar Items
-
In silico study of various antiviral drugs, vitamins, and natural substances as potential binding compounds with SARS-CoV-2 main protease
by: Michael Alabboud, et al.
Published: (2020-07-01) -
Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (M<sup>pro</sup>)
by: Ahmed M. Sayed, et al.
Published: (2020-06-01) -
The Possible Molecular Mechanism of SARS-CoV-2 Main Protease: New Structural Insights from Computational Methods
by: Alvea Tasneem, et al.
Published: (2021-01-01) -
In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
by: Divya M. Teli, et al.
Published: (2021-01-01) -
In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
by: Baby Krishnaprasad, et al.
Published: (2020-11-01)